Cost-effectiveness analysis of serological prenatal screening for pregnant women in King Abdulaziz University Hospital: a single-center retrospective study
dc.contributor.author | Asiri, Atheer Yahya Saeed | en_US |
dc.contributor.author | Alsawa, Ibtisam Talak Audallah | en_US |
dc.contributor.author | Anas, Mahmoud Omar Fallatah | en_US |
dc.contributor.author | Sondos, Sami Hussein | en_US |
dc.contributor.author | Hisham ,Z. Alshehri | en_US |
dc.contributor.author | Aseel, Ahmed Mohammedali Aljahdali | en_US |
dc.contributor.author | Arwa, Zuhair Fatani | en_US |
dc.contributor.author | Samera, Albasri | en_US |
dc.date.accessioned | 2020-05-06T09:52:57Z | |
dc.date.available | 2020-05-06T09:52:57Z | |
dc.date.issued | 2020-01 | |
dc.description.abstract | Background: Congenital primary infections with Toxoplasma gondii, cytomegalovirus (CMV), Epstein–Bar virus (EBV), rubella, and hepatitis B virus (HBV) are viral infections transmitted transplacentally through the blood to the fetus and can be life-threatening. Therefore, we aimed to determine the prevalence of these infections and assess the cost-effectiveness of blood tests among pregnant women with positive serologies.Methods: This retrospective review was conducted among pregnant women with positive prenatal screening serology test results between January 2013 to July 2018. A p-value of <0.05 was used to calculate statistical significance.Results: Overall, 9095 pregnant women delivered in the last 5 years. Of these, 97 had positive prenatal screening serology and were enrolled in our study. Of 97, 61 (62.9%) were Saudis and 36 (37.1%) non-Saudis. The prevalence rates of rubella, CMV, EBV, and HBV were 78.35%, 59.79%, 14.43%, and 5.15%, respectively. Additionally, 44 of 97 women developed undesired antepartum outcomes, whereas 47 had adverse neonatal outcomes. CMV, HBV, and rubella were significantly associated with adverse pregnancy outcomes (P<0.005). During the study period, USD 1460228.27 was spent to screen 9095 pregnant women and USD 15573.68 to diagnose 97 pregnant women with positive serology.Conclusions: Because infections with toxoplasma, CMV, EBV, rubella, and HBV can cause serious risk to the mother and fetus during pregnancy. Thus, setting new hospital policies regarding early screening for high-risk pregnancies and early detection of these infections during prenatal visits are inevitable to avoid undesired outcomes. | en_US |
dc.identifier.affiliations | College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia | en_US |
dc.identifier.affiliations | College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia | en_US |
dc.identifier.affiliations | College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia | en_US |
dc.identifier.affiliations | College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia | en_US |
dc.identifier.affiliations | College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia | en_US |
dc.identifier.affiliations | College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia | en_US |
dc.identifier.affiliations | College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia | en_US |
dc.identifier.affiliations | Department of Oobstetrics and Ggynecology, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia | en_US |
dc.identifier.citation | Asiri Atheer Yahya Saeed, Alsawa Ibtisam Talak Audallah, Anas Mahmoud Omar Fallatah, Sondos Sami Hussein, Hisham Z. Alshehri, Aseel Ahmed Mohammedali Aljahdali, Arwa Zuhair Fatani, Samera Albasri. Cost-effectiveness analysis of serological prenatal screening for pregnant women in King Abdulaziz University Hospital: a single-center retrospective study. International Journal of Community Medicine and Public Health. 2020 Jan; 7(1): 54-60 | en_US |
dc.identifier.issn | 2394-6032 | |
dc.identifier.issn | 2394-6040 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/202112 | |
dc.language | en | en_US |
dc.publisher | Medip Academy | en_US |
dc.relation.issuenumber | 1 | en_US |
dc.relation.volume | 7 | en_US |
dc.source.uri | https://dx.doi.org/10.18203/2394-6040.ijcmph20195832 | en_US |
dc.subject | Prenatal screening | en_US |
dc.subject | Congenital primary infections | en_US |
dc.subject | Fetal health | en_US |
dc.title | Cost-effectiveness analysis of serological prenatal screening for pregnant women in King Abdulaziz University Hospital: a single-center retrospective study | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1